Nerve invasion linked to poorer disease-free survival in salivary duct cancer
A prognostic review found an adverse disease-free survival association, with greater uncertainty for overall and disease-specific survival.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Cancer involving the spaces around nerves was associated with poorer disease-free survival in this review of salivary duct carcinoma. Results were less conclusive for overall and disease-specific survival, whose confidence intervals included no association. This prognostic evidence does not establish that nerve involvement caused worse outcomes or identify an effective treatment.
This abstract-based summary lacks study and patient counts, follow-up durations and adjustment details. It cannot establish whether other tumor features explain the association; disease-free survival events are not defined.
What researchers found
Disease-free survival
The hazard ratio estimates 3.32 times the rate of events ending disease-free survival with nerve invasion versus without, at a given follow-up point. It is not an absolute probability or a survival-time ratio; follow-up length was unreported.
The feature studied
Perineural invasion means tumor cells have entered or surrounded spaces associated with nerves. The researchers examined how common this feature was and how it related to subsequent survival.
Different survival endpoints
The pooled survival result was unfavorable overall, but certainty differed by endpoint. Overall and disease-specific survival estimates were compatible with no association, requiring more caution than the abstract's broad conclusion suggests.
The original publication
Prognostic significance of perineural invasion in salivary duct carcinoma: A systematic review and meta-analysis.
Abbas R, Krishna R, Augustine J et al.
Crit Rev Oncol Hematol · 2026
- PubMed ID
- 41455579
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.